These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30611982)

  • 21. Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.
    Zhang R; Yu R; Xu Q; Li X; Luo J; Jiang B; Wang L; Guo S; Wu N; Shi D
    Eur J Med Chem; 2017 Jul; 134():24-33. PubMed ID: 28395151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
    Chen X; Liu X; Gan Q; Feng C; Zhang Q
    Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of selective binding of inhibitors to PTP1B and TCPTP by accelerated molecular dynamics simulations.
    Chen X; Gan Q; Feng C; Liu X; Zhang Q
    J Biomol Struct Dyn; 2019 Sep; 37(14):3697-3706. PubMed ID: 30238851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 2-substituted ethenesulfonic acid ester derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatase 1B.
    Deng X; Liu J; Jin Y; Zhang Y; He W; Bao J; Liu W; Jiang F; Fu L
    Pharmazie; 2015 Dec; 70(12):777-83. PubMed ID: 26817274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prunin is a highly potent flavonoid from Prunus davidiana stems that inhibits protein tyrosine phosphatase 1B and stimulates glucose uptake in insulin-resistant HepG2 cells.
    Jung HA; Ali MY; Bhakta HK; Min BS; Choi JS
    Arch Pharm Res; 2017 Jan; 40(1):37-48. PubMed ID: 27798765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
    Prabhakar PK; Sivakumar PM
    Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B).
    Liljebris C; Martinsson J; Tedenborg L; Williams M; Barker E; Duffy JE; Nygren A; James S
    Bioorg Med Chem; 2002 Oct; 10(10):3197-212. PubMed ID: 12150865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
    Shinde RN; Kumar GS; Eqbal S; Sobhia ME
    PLoS One; 2018; 13(6):e0199020. PubMed ID: 29912965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling.
    Erbe DV; Klaman LD; Wilson DP; Wan ZK; Kirincich SJ; Will S; Xu X; Kung L; Wang S; Tam S; Lee J; Tobin JF
    Diabetes Obes Metab; 2009 Jun; 11(6):579-88. PubMed ID: 19383031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple machine learning based descriptive and predictive workflow for the identification of potential PTP1B inhibitors.
    Chandra S; Pandey J; Tamrakar AK; Siddiqi MI
    J Mol Graph Model; 2017 Jan; 71():242-256. PubMed ID: 28006676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 - 2014).
    Tamrakar AK; Maurya CK; Rai AK
    Expert Opin Ther Pat; 2014 Oct; 24(10):1101-15. PubMed ID: 25120222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein Tyrosine Phosphatase 1B Inhibition and Glucose Uptake Potentials of Mulberrofuran G, Albanol B, and Kuwanon G from Root Bark of
    Paudel P; Yu T; Seong SH; Kuk EB; Jung HA; Choi JS
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis.
    Tiganis T
    FEBS J; 2013 Jan; 280(2):445-58. PubMed ID: 22404968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stearic acid serves as a potent inhibitor of protein tyrosine phosphatase 1B.
    Tsuchiya A; Kanno T; Nishizaki T
    Cell Physiol Biochem; 2013; 32(5):1451-9. PubMed ID: 24296476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
    Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
    Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
    Panzhinskiy E; Ren J; Nair S
    Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.